​

Ernexa Therapeutics Ownership | Who Owns Ernexa Therapeutics?


OverviewFinancialsChart

Ernexa Therapeutics Ownership Summary


Ernexa Therapeutics is owned by 4.57% institutional investors, 26.74% insiders, and 68.69% retail investors. Geode capital management is the largest institutional shareholder, holding 1.36% of ERNA shares. Fidelity Extended Market Index is the top mutual fund, with 0.79% of its assets in Ernexa Therapeutics shares.

ERNA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockErnexa Therapeutics4.57%26.74%68.69%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryBiotech Stocks 180.58%11.62%-92.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management16.08K1.36%$51.45K
Vanguard fiduciary trust8.34K0.70%$26.68K
Vanguard capital management5.68K0.48%$18.19K
Tradewinds capital management4.61K0.39%$14.75K
Morgan stanley200.000.02%$640.00
Citigroup102.000.01%$326.00
Blackrock funding, inc. /de33.000.00%$106.00
Ubs group19.000.00%$61.00
Bnp paribas arbitrage, snc1.000.00%$3.00
Montag a & associates---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tradewinds capital management4.61K0.00%$14.75K
Vanguard personalized indexing management---
Assetmark---
Two sigma securities---
Eversource wealth advisors---
Montag a & associates---
Cypress point wealth management---
Jane street group---
Ci private wealth---
Geode capital management16.08K-$51.45K

Top Buyers

HolderShares% AssetsChange
Geode capital management16.08K-16.08K
Tradewinds capital management4.61K0.00%4.25K
Morgan stanley200.00-200.00
Citigroup102.00-102.00
Ubs group19.00-19.00

Top Sellers

HolderShares% AssetsChange
Bleichroeder lp---2.00M
Dauntless investment group---612.44K
Ci private wealth---438.09K
Two sigma securities---229.34K
Cypress point wealth management---94.38K

New Positions

HolderShares% AssetsChangeValue
Geode capital management16.08K-16.08K$51.45K
Morgan stanley200.00-200.00$640.00
Citigroup102.00-102.00$326.00
Ubs group19.00-19.00$61.00

Sold Out

HolderChange
Activest wealth management-3.00
Sbi securities-6.00
Montag a & associates-8.00
Group one trading-19.00
Jpmorgan chase-53.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20261233.33%54,07552.22%450.69%7600.00%1-87.50%
Jun 30, 20269-52.63%35,525-99.01%30.92%1-92.31%8-
Mar 31, 202619-3,574,358-18-19---
Mar 31, 2025268.33%1,488,38549.68%25.25%129.09%525.00%
Dec 31, 20242420.00%994,39339.80%74.22%11120.00%433.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index12.91K0.79%-27.00
Vanguard Institutional Extnd Mkt Idx Tr5.68K0.49%-
NT Ext Equity Mkt Index Fund - NL1.52K0.13%1.52K
Fidelity Series Total Market Index1.60K0.10%-
NT Ext Equity Mkt Idx Fd - DC - NL - T21.10K0.09%1.10K
BlackRock Extended Equity Market K2.28K0.04%-1.00
Cinvest Azero Global FI537.000.03%-
Fidelity Nasdaq Composite Index1.17K0.02%-
Vanguard Total Stock Mkt Idx Inv12.09K0.02%-
SSgA U.S. Extended Market Index Class I766.000.01%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 10, 2026Cherington Charles-Buy$2.72M
Feb 10, 2026Cherington Charles-Buy$2.00M
Jun 09, 2025Cherington Charles-Buy$2.22M
Sep 24, 2024Cherington Charles-Buy$2.24M
Sep 24, 2024Cherington Charles-Buy-

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q12-
2025 Q22-
2025 Q1--
2024 Q473

ERNA Ownership FAQ


Who Owns Ernexa Therapeutics?

Ernexa Therapeutics shareholders are primarily institutional investors at 4.57%, followed by 26.74% insiders and 68.69% retail investors. The average institutional ownership in Ernexa Therapeutics's industry, Biotech Stocks , is 180.58%, which Ernexa Therapeutics falls below.

Who owns the most shares of Ernexa Therapeutics?

Ernexa Therapeutics’s largest shareholders are Geode capital management (16.08K shares, 1.36%), Vanguard fiduciary trust (8.34K shares, 0.70%), and Vanguard capital management (5.68K shares, 0.48%). Together, they hold 2.54% of Ernexa Therapeutics’s total shares outstanding.

Does Blackrock own Ernexa Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Ernexa Therapeutics.

Who is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested?

Tradewinds capital management is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 4.61K Ernexa Therapeutics shares, valued at 14.75K$.

Who is the top mutual fund holder of Ernexa Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Ernexa Therapeutics shares, with 0.79% of its total shares outstanding invested in 12.91K Ernexa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools